Showing results (21-30 of 6,995) with videos related to

Sort By:
Pageof 700
Lung Cancer (Amsterdam, Netherlands)|May 3, 2016
Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene statusTejas Patil, Dara L Aisner, Sinead A Noonan, et al.
Lung Cancer (Amsterdam, Netherlands)|May 3, 2016
Advanced nodal stage predicts venous thromboembolism in patients with locally advanced non-small cell lung cancerRichard Li, Gretchen Hermann, Elizabeth Baldini, et al.
Lung Cancer (Amsterdam, Netherlands)|May 3, 2016
Low forced vital capacity predicts cytotoxic chemotherapy-associated acute exacerbation of interstitial lung disease in patients with lung cancerYasunori Enomoto, Naoki Inui, Terufumi Kato, et al.
Lung Cancer (Amsterdam, Netherlands)|May 3, 2016
Evaluation of the combination of oxaliplatin and 5-fluorouracil or gemcitabine in patients with sporadic metastatic pulmonary carcinoid tumorsT Walter, D Planchard, K Bouledrak, et al.
Lung Cancer (Amsterdam, Netherlands)|May 3, 2016
Impact of whole brain radiation therapy on CSF penetration ability of Icotinib in EGFR-mutated non-small cell lung cancer patients with brain metastases: Results of phase I dose-escalation studyLin Zhou, Jiazhuo He, Weijie Xiong, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2016
Metformin use and survival from lung cancer: A population-based cohort studyÚna C Mc Menamin, Chris R Cardwell, Carmel M Hughes, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2016
Diagnostic accuracy of sequential co-registered PET+MR in comparison to PET/CT in local thoracic staging of malignant pleural mesotheliomaKatharina Martini, Andreas Meier, Isabelle Opitz, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2016
Monitoring of treatment responses and clonal evolution of tumor cells by circulating tumor DNA of heterogeneous mutant EGFR genes in lung cancerFumio Imamura, Junji Uchida, Yoji Kukita, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2016
Metabolic tumor burden as marker of outcome in advanced EGFR wild-type NSCLC patients treated with erlotinibAnne Winther-Larsen, Joan Fledelius, Boe Sandahl Sorensen, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2016
A sensitive and high throughput TaqMan-based reverse transcription quantitative polymerase chain reaction assay efficiently discriminates ALK rearrangement from overexpression for lung cancer FFPE specimensJrhau Lung, Yu-Ching Lin, Ming-Szu Hung, et al.
Pageof 700